Movement Disorders - Medicare Access (Medicare patients only)

Status

Closed
Closed Funds

This fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.

Fund Type

Copay/Premium

Maximum Award Level

$10,000

Pharmacy Card Fund

Yes

Minimum Copay
Reimbursement Amount

Minimum Copay Reimbursement Amount

We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.

None

Minimum Premium
Reimbursement Amount

Minimum Premium Reimbursement Amount

We encourage you to please submit monthly reimbursement claims (even if your premium is paid on a bi-weekly basis).

None

Household Income Limit

500% of the Federal Poverty Level
(adjusted for household size and high
cost of living areas)

Fund Alerts

Sign up for email or text/call alerts to receive instant notifications.

Treatments Covered

  • Abilify
  • Abilify Asimtufi
  • Abilify Maintena
  • Abilify Mycite Maintenance Kit
  • Abilify Mycite Starter Kit
  • Amantadine
  • Amantadine Hcl
  • Amantadine Hcl Avpak
  • Amantadine Hydrochloride
  • Amerinet Choice Metoclopramide
  • Amytal Sodium
  • Anaspaz
  • Antiflex
  • Apokyn
  • Apomorphine Hcl
  • Apomorphine Hydrochloride Hemihydrate
  • Aripiprazole
  • Aripiprazole Lauroxil
  • Aristada
  • Aristada Initio
  • Austedo
  • Austedo Xr
  • Austedo Xr Titration Kit
  • Azilect
  • Baclofen
  • Baclofen Avpak
  • Belladonna
  • Belladonna Tincture
  • Benztropine
  • Benztropine Mesylate
  • Botox
  • Botox Cosmetic
  • Bromocriptine Mesylate
  • Carbidopa
  • Carbidopa Levodopa Entacapone
  • Carbidopa Levodopa
  • Catapres-tts-1
  • Catapres-tts-2
  • Catapres-tts-3
  • Clonadine Hcl Avpak
  • Clonazepam
  • Clonazepam Avpak
  • Clonidine
  • Clonidine Hcl
  • Creatine
  • Creatine Monohydrate
  • Crexont
  • Cycloset
  • Dhivy
  • Diphenhydramine Hcl
  • Diphenhydramine Hydrochloride
  • Duopa
  • Duraclon
  • Dysport
  • Ed-spaz
  • Eldepryl
  • Emsam
  • Entacapone
  • Entacapone Avpak
  • Eprontia
  • Exservan
  • Fleqsuvy
  • Fluphenazine Decanoate
  • Fluphenazine Hcl
  • Fluphenazine Hcl Avpak
  • Gablofen
  • Geodon
  • Gimoti
  • Gocovri
  • Guanfacine Hcl
  • Guanfacine Hcl Avpak
  • Haldol Deconoate
  • Haloperidol
  • Haloperidol Amerinet Choice
  • Haloperidol Decanoate
  • Haloperidol Decanoate Novaplus
  • Haloperidol Deconoate 50
  • Haloperidol Lactate
  • Hycoscyamine
  • Hyoscyamine Sulfate
  • Hyosyne
  • Inbrija
  • Ingrezza
  • Ingrezza Sprinkle
  • Intuniv
  • Klonopin
  • L-dopa
  • Levbid
  • Levodopa
  • Levsin
  • Levsin/sl
  • Lioresal
  • Lioresal Intrathecal
  • Lodosyn
  • Lyvispah
  • Metoclopramide
  • Metoclopramide Hcl
  • Metoclopramide Hcl Monohydrate
  • Mirapex
  • Mirapex Er
  • Natural Mixed Tocopherols
  • Nembutal
  • Neupro
  • Nexiclon Xr
  • Nicotrol (device/spray) Non Otc
  • Nicotrol Ns
  • Nourianz
  • Nulev
  • Olanzapine
  • Olanzapine Avpak
  • Olanzapine Pamoate
  • Ongentys
  • Orphenadrine Citrate
  • Oscimin
  • Osmolex Er
  • Ozobax
  • Ozobax Ds
  • Parlodel
  • Pentobarbital Sodium
  • Perseris
  • Pimozide
  • Pramipexole Dihydrochloride
  • Premierpro Rx Fluphenazine Decanoate
  • Premierpro Rx Geodon
  • Premierpro Rx Haloperidol
  • Premierpro Rx Haloperidol Decanoate
  • Premierpro Rx Metoclopramide Hcl
  • Premierpro Rx Olanzapine
  • Pyridoxine Hcl
  • Qudexy Xr
  • Rasagiline
  • Rasagiline Mesylate
  • Reglan
  • Requip Xl
  • Rilutek
  • Riluzole
  • Risperdal
  • Risperdal Consta
  • Risperidone
  • Risperidone M-tab
  • Risperidone Odt
  • Ropinirole
  • Ropinirole Hcl
  • Ropinirole Hcl Avpak
  • Rykindo
  • Rytary
  • Scopolamine
  • Selegiline Hcl
  • Simplist Haloperidol
  • Simplist Metoclopramide Hcl
  • Sinemet 10-100
  • Sinemet 25-100
  • Symax Duotab
  • Symax Fastabs
  • Symax-sl
  • Symax-sr
  • Tasmar
  • Teglutik
  • Tetrabenazine
  • Tiglutik
  • Tolcapone
  • Topamax
  • Topiramate
  • Transderm Scop
  • Trazodone Hydrochloride
  • Trazodone Hydrochloride Avpak
  • Trihexyphenidyl Hcl
  • Trokendi Xr
  • Uzedy
  • Valbenazine
  • Xadago
  • Xenazine
  • Zelepar
  • Ziprasidone Hcl
  • Ziprasidone Hcl Avpak
  • Ziprasidone Mesylate
  • Zonegran
  • Zonisade
  • Zonisamide
  • Zonisamide Avpak
  • Zyprexa
  • Zyprexa Intramuscular
  • Zyprexa Relprevv
  • Zyprexa Zydis

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment of movement disorders including: Tardive Dyskinesia, General Dyskinesia, Huntington’s Disease, Choreas, Tourette Syndrome and Parkinson’s Disease.

Grant Utilization

HealthWell estimates that patients use an average of $5,540 during their 12-month grant period for this disease area.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

About Our Movement Disorders Fund

This fund offers copayment or premium assistance for eligible Medicare beneficiaries in several different movement-related disease areas, including, but not limited to:

  • Chorea is an abnormal involuntary movement derived from the Greek word “dance”. It is characterized by brief, abrupt, irregular, unpredictable, non-stereotyped movements. In milder cases, they may appear purposeful; the patient often appears fidgety and clumsy. They can affect various body parts, and interfere with speech, swallowing, posture and gait. Source: International Parkinson and Movement Disorder Society

  • Tardive dyskinesia is caused by long-term use of neuroleptic drugs, which are used to treat psychiatric conditions. Tardive dyskinesia causes repetitive, involuntary movements, such as grimacing and eye blinking. Source: Mayo Clinic

  • Huntington’s disease (HD) is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain. It deteriorates a person’s physical and mental abilities during their prime working years and has no cure. HD is known as the quintessential family disease because every child of a parent with HD has a 50/50 chance of carrying the faulty gene. Source: Huntington’s Disease Society of America

  • Tourette Syndrome is one type of Tic Disorder. Tics are involuntary, repetitive movements and vocalizations. They are the defining feature of a group of childhood-onset, neurodevelopmental conditions known collectively as Tic Disorders. Individuals with Tourette Syndrome (TS) have had at least two motor tics and at least one vocal/ phonic tic in some combination over the course of more than a year. Source: Tourette Association of America

  • Parkinson’s disease affects the nerve cells in the brain and slowly stops producing a neurotransmitter called dopamine. With less and less dopamine, a person has less and less ability to regulate their movements, body and emotions.

    Parkinson’s disease itself is not fatal. However, complications from the disease are serious; the Centers for Disease Control and Prevention (CDC) rated complications from PD as the 14th top cause of death in the United States.

    There is currently no cure for Parkinson’s. Source: National Parkinson’s Foundation

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • This is a Medicare Access Fund. In order to qualify for assistance through this fund, you must have Medicare. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.

  • HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.